Revenue Growth Fuels Strong Operating Metrics Pantheris SV Limited Launch at Key U.S. Sites in July REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with […]
Other News
iRhythm Technologies Announces Second Quarter 2019 Financial Results
SAN FRANCISCO, July 31, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ending June 30, 2019. Second Quarter 2019 and Recent Highlights Revenue of $53.3 million for the […]
Teleflex Announces Publication of “Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device”
WAYNE, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) today announced the publication of the “Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.” The SAFE MANTA IDE Clinical Trial, the largest U.S. prospective multi-center study of a purpose-designed large […]
BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System
Westport, CT, Aug. 01, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the US Patent Office has allowed another foundational patent including additional 29 patent claims […]
Endotronix Announces FDA Approval to Begin Landmark PROACTIVE-HF Pivotal Trial for Cordella™ PA Pressure Sensor System
LISLE, Ill., Aug. 1, 2019 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin the multi-center PROACTIVE-HF trial of the Cordella™ Pulmonary […]
Leviticus Cardio Appoints Prof. Nir Uriel to its Scientific Advisory Board
PETAH-TIKVA, Israel, Aug. 1, 2019 /PRNewswire/ — Leviticus Cardio today announced the appointment of Prof. Nir Urielto its Scientific Advisory Board. “We are very excited that Prof. Uriel has joined our Scientific Advisory Board. He is a leader in the field of heart failure, mechanical circulatory support and heart transplantation, and he will help us greatly in promoting our […]
FRESH 3D Printing Used to Rebuild Functional Components of Human Heart
ACTON, Mass., Aug. 1, 2019 /PRNewswire/ — Scientists have taken a major step closer to being able to 3D bioprint functional organs, after researchers devised a method of rebuilding components of the human heart, according to a study published in the August 2nd edition of Science. The team of Carnegie Mellon University researchers developed an advanced version […]
Zynex Announces 2019 Second Quarter Earnings
– Revenue increased 36% year over year to $10.3 million – Orders increased 65% year over year – Net income $2.2 million; Diluted EPS $0.06 – Adjusted EBITDA $2.8M – Twelfth consecutive quarter of positive net income ENGLEWOOD, Colo., July 31, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing […]
Adagio Medical Treats First Persistent Atrial Fibrillation Patient With One Shot+™ Cryoablation Catheter Utilizing Only Anatomical Markers For Accurate Imaging
LAGUNA HILLS, Calif., July 31, 2019 /PRNewswire/ — Adagio Medical, Inc., the developer of iCLAS™, the company’s ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces that the first PsAF patient was successfully treated with its new One Shot+™ cryoablation catheter in a procedure that utilizes only anatomical markers with limited usage […]
Abiomed Announces Q1 FY 2020 Revenue of $208 Million and 29.2% Operating Margin
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported first quarter fiscal 2020 revenue of $207.7 million, an increase of 15.4% compared to revenue of $180.0 million for the same period of fiscal 2019. Operating income was $60.7 million, up 30%, compared […]



